[The significance of proteinase inhibitors in lacrimal fluid (author's transl)].
The significance of proteinase inhibitors in lacrimal fluid is discussed. While an increase is diagnostically important, localized deficiencies may lead to serious symptoms. To our knowledge this is the first time that local antiproteinase treatment has been described.
D000368:Aged; D000818:Animals; D001424:Bacterial Infections / Q000378:metabolism; D003320:Corneal Ulcer / Q000150:complications / Q000601:surgery; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007634:Keratitis / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000150:complications; D010455:Peptides / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000032:analysis*; D011817:Rabbits; D013666:Tears / Q000032:analysis / Q000201:enzymology*; D000515:alpha 1-Antitrypsin / Q000378:metabolism; D019896:alpha 1-Antitrypsin Deficiency
D010455:Peptides; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin
Die Bedeutung von Proteinaseinhibitoren in der Tränenflüssigkeit.